肺癌や悪性腫瘍 タルラタマブ、実際どうなのか? 小細胞肺癌のリアルワールドデータ:CRS・ICANSのリスク因子は?
Risk factors for CRS and ICANS with tarlatamab in small cell lung cancer and associated efficacy outcomes: Insights from clinical practice. Sarah Blocker et al. European Journal of Cancer, 2026小細胞肺癌は再...